20+ yrs in development and commercialization of regulated healthcare technologies; (2) successful exits as management; experienced with FDA, EMA; trained in intellectual property; formerly licensed as Analyst with SEC/FINRA.
20+ years experience with pharmaceutical product manufacture and development, from synthesis to finished drug product and use thereof in multiple clinical development programs; experienced with FDA, EMA.
25 + years in clinical operations in drug/device trials, including various acute care indications from Phase 1 to Phase 3 trials. Several years at senior level positions in biotech startups. Extensive experience in the management of multi-center trials in US and EU.
Contracted through VCFO.com
Extensive finance experience in early- and growth-stage technology companies.
Highly trained mechanical engineer with experience developing surgical technologies and analytical software. Skilled in modeling, materials testing, and statistical analysis and responsible for device development.
20+ years of experience with healthcare technology start-ups and investment firms. Currently he is CEO of Prevacept, Inc., Partner at Charter Lifescience Ventures, is an active angel investor and serves on several Boards.
Former semiconductor executive and entrepreneur, now a consultant and active angel investor with start-up investments in more than 40 companies including 16 companies with whom John has served or currently as a Board member. Director for the Central Texas Angel Network from 2011 through present.